Clinical Trial Update: A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]

View source ↗

Summary

A Phase II, single-arm trial evaluating everolimus (RAD001) in combination with letrozole and metformin for advanced or recurrent endometrial cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Everolimus (everolimus)
• Letrozole (letrozole)
• metformin (metformin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING